UNSPSC 85722333: Revision of nonautologous tissue substitute in left metatarsal-tarsal joint, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in left metatarsal-tarsal joint, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWL4KZ

UNSPSC 85722333, Revision of nonautologous tissue substitute in left metatarsal-tarsal joint, percutaneous endoscopic approach, is a Commodity code that shows no meaningful alignment with recent state and local procurement activity. The code nominally describes a highly specific orthopedic surgical procedure, but the six recent opportunities posted under this classification span independent medical evaluation services for pension disability determinations, surgical benefit carve-out networks, occupational health surveillance, youth detention emergency medical services, pharmacy benefit management, and temporary health professional staffing—none of which involve tissue revision or joint surgery procurement. This represents a significant mismatch between the code's clinical specificity and the actual work state and local agencies are buying under it.

The recent opportunities originate from diverse issuing bodies: the City of Phoenix Retirement Office (Arizona), City of Long Beach (California), Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and Santa Clara County Health System (California). Geographic spread includes Arizona, California, Florida, Texas, and Washington. The absence of coherent product or service overlap across these solicitations, combined with the code's narrow procedural description, suggests either a systematic tagging error in the underlying procurement database or that this code is not actively used for genuine state and local procurement of tissue substitutes or orthopedic procedures. Business development professionals should treat this code as inactive for practical contracting purposes and verify directly with issuing bodies if pursuing work in orthopedic implant supply, surgical services, or medical device distribution.